Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.13% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
iShares Core MSCI Europe ETF
IEUR
$8.71B
| $632K | ﹤0.01% |
+9,000
| New | +$657K |
|
2502
Rocky Mountain Chocolate Factory
RMCF
$8.95M
| $632K | ﹤0.01% |
280,918
-1,005
| -0.4% | -$2.35K |
|
2503
Expensify
EXFY
$172M
| $631K | ﹤0.01% |
725,000
+45,400
| +7% | +$53.9K |
|
2504
Knife River
KNF
$4.48B
| $629K | ﹤0.01% |
7,700
-108,400
| -93% | -$8.73M |
|
2505
Definitive Healthcare
DH
$72.1M
| $629K | ﹤0.01% |
511,140
-16,500
| -3% | -$28.7K |
|
2506
Stepan Co
SCL
$1.32B
| $625K | ﹤0.01% |
12,512
-6,415
| -34% | -$343K |
|
|
DOYU
2507
DouYu International Holdings
DOYU
$138M
| $625K | ﹤0.01% |
124,426
+8,088
| +7% | +$46.4K |
|
|
DAO
2508
Youdao
DAO
$1.87B
| $624K | ﹤0.01% |
63,500
+1,500
| +2% | +$15.7K |
|
|
IONX
2509
Defiance Daily Target 2X Long IONQ ETF
IONX
$97.9M
| $624K | ﹤0.01% |
+30,000
| New | +$1.34M |
|
2510
Atomera
ATOM
$208M
| $621K | ﹤0.01% |
+163,066
| New | +$614K |
|
|
DDI
2511
DoubleDown Interactive
DDI
$569M
| $619K | ﹤0.01% |
73,256
+19,256
| +36% | +$169K |
|
2512
Gibraltar Industries
ROCK
$1.35B
| $618K | ﹤0.01% |
15,500
-23,600
| -60% | -$1.14M |
|
2513
WidePoint Corp
WYY
$108M
| $617K | ﹤0.01% |
123,598
-8,500
| -6% | -$46.9K |
|
2514
Ginkgo Bioworks
DNA
$500M
| $616K | ﹤0.01% |
+100,456
| New | +$836K |
|
2515
Betterware México
BWMX
$644M
| $614K | ﹤0.01% |
36,400
-800
| -2% | -$14K |
|
|
XRN
2516
Chiron Real Estate Inc
XRN
$541M
| $612K | ﹤0.01% |
18,497
| – | – |
|
2517
Exagen
XGN
$116M
| $610K | ﹤0.01% |
203,272
+65,272
| +47% | +$252K |
|
|
ONCY
2518
Oncolytics Biotech
ONCY
$98M
| $608K | ﹤0.01% |
+715,838
| New | +$712K |
|
2519
Prenetics Global
PRE
$329M
| $605K | ﹤0.01% |
31,322
+14,400
| +85% | +$268K |
|
|
SCHV
2520
Schwab US Large-Cap Value ETF
SCHV
$15.8B
| $604K | ﹤0.01% |
19,800
-27,800
| -58% | -$866K |
|
2521
Schwab US Mid-Cap ETF
SCHM
$14.7B
| $604K | ﹤0.01% |
+19,500
| New | +$621K |
|
2522
Revolution Medicines
RVMD
$40.3B
| $603K | ﹤0.01% |
+6,200
| New | +$626K |
|
2523
Mid Penn Bancorp
MPB
$945M
| $602K | ﹤0.01% |
+18,731
| New | +$606K |
|
2524
JPMorgan BetaBuilders Canada ETF
BBCA
$10.8B
| $602K | ﹤0.01% |
+6,400
| New | +$612K |
|
2525
Asana
ASAN
$1.56B
| $601K | ﹤0.01% |
93,939
+83,300
| +783% | +$733K |
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.